Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Atherosclerosis Plus|January 8, 2024
CTCA in children with severe heterozygous familial hypercholesterolaemia: Screening for subclinical atherosclerosisM Doortje Reijman, Sibbeliene E van den Bosch, D Meeike Kusters, et al.Paediatric Drugs|February 4, 2015
Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherenceMarjet J A M Braamskamp, D Meeike Kusters, Hans J Avis, et al.Atherosclerosis|June 17, 2015
Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhoodMarjet J A M Braamskamp, D Meeike Kusters, Albert Wiegman, et al.The Journal of Pediatrics|January 31, 2012
Follow-up of children diagnosed with familial hypercholesterolemia in a national genetic screening programHans J Avis, D Meeike Kusters, Maud N Vissers, et al.Journal of Clinical Lipidology|October 2, 2013
Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemiaD Meeike Kusters, Barbarba A Hutten, Brian W McCrindle, et al.Circulation|March 9, 2011
Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic childrenAnouk van der Graaf, Hans J Avis, D Meeike Kusters, et al.The Journal of Pediatrics|April 6, 2015
Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemiaD Meeike Kusters, Maria Caceres, Mauricio Coll, et al.European Heart Journal|March 4, 2014
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcomeBarbara Sjouke, D Meeike Kusters, Iris Kindt, et al.Obesity Research & Clinical Practice|December 28, 2025
Children's experience of screening and evaluation for MASLD in overweight and obesityAnne-Sophie R Stroes, Laura Draijer, Hedy A van Oers, et al.Journal of Clinical Lipidology|December 22, 2015
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON studyMarjet J A M Braamskamp, Gisle Langslet, Brian W McCrindle, et al.Pageof 3